How Much Did Eargo Raise?
Funding & Key Investors

Eargo, a pioneer in the direct-to-consumer medical device sector, has successfully navigated multiple stages of capital infusion to solidify its market position. With a cumulative total of $506.4M raised since its inception, the company has demonstrated a consistent ability to attract high-profile institutional backing. Most recently, the firm secured a major strategic investment of $125M, a move that underscores investor confidence in its proprietary hearing technology and its broader mission to democratize access to high-quality hearing care solutions.

The company's growth trajectory, marked by a series of strategic financing rounds, reflects its evolution from an early-stage innovator to a significant player in the over-the-counter hearing aid market. By leveraging these capital injections, Eargo has effectively scaled its operations, refined its product design, and expanded its reach to consumers seeking discreet, rechargeable, and comfortable hearing devices.